A) Schematic of ISO or EED protocols, tamoxifen (TX) or
vehicle(Veh; corn oil) treatment for RORγT deletion and oral vaccination
and in Foxp3Cre ERT2 Rorcfl/fl mice
(FOXP3RORgT+/−).
(B-E) Data from mice which were treated with
tamoxifen(FOXP3RORgT−) are represented in open circles
while data from vehicle treated controls (FOXP3RORgT+) are in closed
circles.
B) Numbers of LT166-176:I-Ab specific
CD4+ T cells isolated from the siLP and MLNs following oral
vaccination with dmLT (as in Fig. 2A) of
Foxp3Cre ERT2 Rorcfl/fl with and
without tamoxifen treatment. Data is pooled from 2 separate experiments
(n=3/experiment).
C) Concentration of LT-specific IgA in the small intestine
(from PBS lavage) of Foxp3Cre ERT2
Rorcfl/fl mice from mice from B.
D)Foxp3Cre ERT2 Rorcfl/fl mice in the EED
protocol were vaccinated with dmLT, with and without tamoxifen treatment as
shown in 6A. After vaccination (day 42 or 45) mice were colonized with ETEC
H10407 (KanaR) and a day later numbers of bacterial CFU counted on
LB/Kanamycin plates. Data are pooled from 2 separate experiments
(n=3/experiment).
E) Percent weight gain during EED establishment in
FOXP3Cre ERT2 Rorc fl/fl mice with and without
tamoxifen treatment. Dotted lined represent days when CUMT8
E.coli was orally gavaged. Data shown is representative of
2 separate experiments (n=3-4/experiment). Statistics calculated from weights at
day 28.
Graphs show the mean ±SEM. Data points represent a single mouse.
Statistics calculated by one-way ANOVA (*p ≤ 0.05; **p ≤ 0.01;
***p ≤ 0.001; ****p ≤ 0.0001)